POLA-PHARMA

pola-pharma-logo

POLA-Pharma line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use.

#SimilarOrganizations #Website #More

POLA-PHARMA

Industry:
Manufacturing Pharmaceutical

Founded:
2007-01-01

Address:
Higashi-shinagawa, Tokyo, Japan

Country:
Japan

Website Url:
http://www.pola-pharma.co.jp

Total Employee:
11+

Status:
Closed

Contact:
+81-357196663

Technology used in webpage:
SPF Amazon Amazon Tokyo Region Sender ID ASAHINET DNS


Similar Organizations

mj-biopharm-logo

MJ Biopharm

MJ Biopharm is the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use.

panbiotic-laboratories-logo

Panbiotic Laboratories

Panbiotic Laboratories manufactures, fabricates, or processes drugs in pharmaceutical preparations for human or veterinary use.

pfeiffer-pharmaceuticals-logo

Pfeiffer Pharmaceuticals

The company's line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human.

Official Site Inspections

http://www.pola-pharma.co.jp Semrush global rank: 16.52 M Semrush visits lastest month: 38

Unable to get host informations!!!

Loading ...

More informations about "POLA-Pharma"

POLA-Pharma - Crunchbase Company Profile & Funding

POLA-Pharma is located in Higashi-shinagawa, Tokyo, Japan. Who are POLA-Pharma 's competitors? Alternatives and possible competitors to POLA-Pharma may include Panbiotic …See details»

Pola Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Pola Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 13 literature, Disease Domain:Endocrinology and Metabolic Disease, Nervous System Diseases, …See details»

Press Release Sun Pharma to acquire Pola Pharma Inc in Japan

Pola Pharma had annual revenues of approximately US$ 108 million and net loss of US$ 7 million for 12 months ended Dec 2017 on consolidated basis. The equity consideration, on debt free …See details»

Pola Pharma - Ownership and Business Overview - Mergr

Nov 27, 2018 Pola Pharma, Inc. is a pharmaceutical company to healthier, more beautiful skin. Pola Pharma has two factories in Japan to make topical products and injectables. It has …See details»

Pola Pharma - Products, Competitors, Financials, Employees ...

Use the CB Insights Platform to explore Pola Pharma's full profile. Technology Vendors; Recent Research; Newsletter; Media Support; Login; Search company, investor... Who We Serve. …See details»

Sun Pharmaceutical agrees to acquire Japan’s Pola …

Nov 28, 2018 Sun Pharma executive vice-president Kirti Ganorkar said: “This acquisition is in line with our strategy to strengthen our global dermatology presence. “Pola Pharma is a leading dermatology company and it will help us …See details»

Sun Pharma to acquire Pola Pharma - bionity.com

Nov 28, 2018 Sun Pharma to acquire Pola Pharma 28-Nov-2018 - Japan Sun Pharmaceutical Industries Ltd. announced that Sun Pharma has entered into a definitive agreement to acquire …See details»

Pola Pharma, Inc.:Company Profile & Technical …

Pola Pharma, Inc. is a company that provides Clinical trial, Medicine, Cosmetics and more. Pola Pharma, Inc. is headquartered in Japan Tokyo-to. Pola Pharma, Inc. was founded in 2007. …See details»

Nextsource | Company Profile | POLA-Pharma

Find out which companies now offer similar products or services like POLA-Pharma. See if the assets or intellectual property of POLA-Pharma have been acquired by or integrated into other …See details»

Sun Pharma to acquire Japan’s Pola Pharma through arm

“Pola Pharma had annual revenues of approximately 8 million and a net loss of million for 12 months ended December 2017 on a consolidated basis. The equity consideration, on a debt …See details»

Pola Pharma - PitchBook

When was Pola Pharma founded? Pola Pharma was founded in 2007. Where is Pola Pharma headquartered? Pola Pharma is headquartered in Tokyo, Japan. What industry is Pola …See details»

Sun gets dermatology portfolio, 2 plants in Japan with Pola …

Nov 26, 2018 Pola Pharma is on the microsize of the business, producing only about $108 million in revenue and a net loss of $7 million for the 12 months ended December 2017. Sun …See details»

POLA PHARMA’s Competitors, Revenue, Number of Employees

POLA PHARMA is a manufacturer and supplier of dermo-cosmetic products. POLA PHARMA’s primary competitors include Modulus Discovery, Anaeropharma Science, Quantum …See details»

Sun Pharma completes acquisition of Japan-based Pola Pharma

Jan 4, 2019 Pola Pharma is engaged in the manufacture, research and development, sale and distribution of branded and generic products in Japan. Sun Pharma’s BSE filing stated, "Sun …See details»

Pola Pharma Inc. - BioCentury Company Profiles - BCIQ

Pola Pharma Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Pola Pharma in Japan to be Acquired Sun Pharma

Sun Pharmaceutical Industries Ltd. ( “Sun Pharma” including its subsidiaries and/or associate companies), today announced that Sun Pharma has entered into a definitive agreement to …See details»

Sun Pharma to acquire Japan's Pola Pharma for $1 mn; to …

Nov 27, 2018 Pola Pharma had an annual revenue of around $108 million and net loss of $7 million for the 12 months ended December 2017 on a consolidated basis. “The equity …See details»

地域に根差した地元を美しく咲かせる活動「BLOOM OUR TOWN …

株式会社ポーラ(本社:東京都品川区、社長:及川美紀)は、2029年に迎える創業100周年に向けて「私と社会の可能性を信じられる、つながりであふれる社会」をビジョンに掲げ、その …See details»

Pola Pharma to Take Over GSK’s Marketing Authorization for Acne …

Jul 21, 2015 Pola Pharma will take over the marketing authorization in Japan for GlaxoSmithKline’s acne vulgaris drug Duac Combination Gel (clindamycin phosphate + …See details»

GSK, Pola Pharma Join Hands for Marketing of Acne Vulgaris …

Jul 21, 2015 GlaxoSmithKline K.K. (GSK) and Pola Pharma Inc. said on July 17 that they forged a partnership in Japan for the marketing of Duac Combination Gel, a fixed-dose combination …See details»

linkstock.net © 2022. All rights reserved